Inhibition of NF-KB

Details for Australian Patent Application No. 2005267117 (hide)

Owner Cleveland Clinic Foundation

Inventors Gurova, Katerina V.; Gudkov, Andrei V.

Agent Shelston IP

Pub. Number AU-B-2005267117

PCT Pub. Number WO2006/012419

Priority 60/589,637 20.07.04 US

Filing date 20 July 2005

Wipo publication date 2 February 2006

Acceptance publication date 21 June 2012

International Classifications

A61K 31/44 - Non-condensed pyridines

A61P 35/00 Antineoplastic agents

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/012419 Priority application(s): WO2006/012419

21 June 2012 Application Accepted

  Published as AU-B-2005267117

5 July 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 07 Jun 2012 . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

25 October 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 07 Jun 2012

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267118-Electronic image acquisition for gaming systems in order to authorize payment documents

2005267111-Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same